Evidence map›Paper›PMID 25953365›Full record

Trial reportStroke2015

Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes.

Mahmud Mossa-Basha, William D Hwang, Adam De Havenon, Daniel Hippe, Niranjan Balu, Kyra J Becker, David T Tirschwell, Thomas Hatsukami, Yoshimi Anzai, Chun Yuan

4 registry-linked trialsAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Stroke, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03507374 early_phase1terminatedstarted 2018, after this paper: background citation

PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis

Ran2018Enrolled20Registered outcomes5Posted comparisons0ConditionsIntracranial Atherosclerosis, Intraplaque Hemorrhage, StrokeArmsAlirocumab, Placebo
Open the trial in the graph
NCT02719652 unknown statusnot on this map

Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis

TypeobservationalSponsorXiuhai GuoRan2015 to 2017Enrolled300ConditionsIntracranial Atherosclerosis
NCT03417063 unknown statusnot on this mapstarted 2017, after this paper: background citation

Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression (ICASMAP)

Typeobservational_patient_registrySponsorTsinghua UniversityRan2017 to 2022Enrolled300ConditionsIschemic Stroke, Transient Ischemic Attack, Intracranial Artery Stenosis
NCT05907629 recruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

TypeobservationalSponsorYale UniversityRan2024 to 2029Enrolled300ConditionsStroke, Intracranial Atherosclerotic Stenosis (ICAS)ArmsMRI
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Intracranial vessel wall lesions on MRI: anatomical and pathological issues.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  10. Inter-rater reliability of atherosclerotic plaque enhancement on 7 T vessel wall MRI: Comparison with quantitative analysis.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  11. Article
  12. Review
  13. Post-infectious central nervous system vasculitides in adults: an underdiagnosed and treatable disease part II. Neuroimaging of selected etiologies : Part II. Neuroimaging of selected etiologies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahmud Mossa-BashaFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.). mmossab@uw.edu.
William D HwangFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Adam De HavenonFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Daniel HippeFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Niranjan BaluFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Kyra J BeckerFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
David T TirschwellFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Thomas HatsukamiFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Yoshimi AnzaiFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).
Chun YuanFrom the Departments of Radiology (M.M.-B., W.D.H., D.H., N.B., Y.A., C.Y.) Neurology (K.J.B., D.T.T.), and Vascular Surgery (T.H.), University of Washington, Seattle; Department of Neurology, University of Utah, Salt Lake City (A.D.H.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAlthough studies have attempted to differentiate intracranial vascular disease using vessel wall magnetic resonance imaging (VWI), none have incorporated multicontrast imaging. This study uses T1- and T2-weighted VWI to differentiate intracranial vasculopathies.

methodsWe retrospectively reviewed patients with clinically defined intracranial vasculopathies causing luminal stenosis/irregularity who underwent VWI studies. Two blinded experts evaluated T1 precontrast and postcontrast and T2-weighted VWI characteristics, including the pattern of wall thickening; presence, pattern, and intensity of postcontrast enhancement; and T2 signal characteristics.

resultsTwenty-one cases of atherosclerosis (intracranial atherosclerotic disease [ICAD]), 4 of reversible cerebral vasoconstriction syndrome, and 4 of vasculitis were identified, with a total of 118 stenotic lesions (81 ICAD, 22 reversible cerebral vasoconstriction syndrome, and 15 vasculitic lesions). There was substantial to excellent inter-reader agreement for the assessment of lesional T2 hyperintensity (κ=0.80), pattern of wall thickening (κ=0.87), presence (κ=0.90), pattern (κ=0.73), and intensity (κ=0.77) of enhancement. ICAD lesions were significantly more likely to have eccentric wall involvement (90.1%) than reversible cerebral vasoconstriction syndrome (8.2%; P<0.001) and vasculitic lesions (6.7%; P<0.001) and were also more likely to have T2 hyperintensity present than the other 2 vasculopathies (79% versus 0%; P<0.001). There were also significant differences in the presence, intensity, and pattern of enhancement between all lesion types. Combining T1 and T2 VWI increased the sensitivity of VWI in differentiating ICAD from other vasculopathies from 90.1% to 96.3%.

conclusionsMulticontrast VWI can be a complementary tool for intracranial vasculopathy differentiation, which often leads to more invasive workups when reversible cerebral vasoconstriction syndrome and vasculitis are in the differential diagnosis.

Indexed as

AgedCerebral AngiographyCerebrovascular DisordersDiagnosis, DifferentialHumansMagnetic Resonance AngiographyMaleMiddle Agedintracranial vasculopathymagnetic resonance imagingvascular diseases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.